Carlsbad, California — TAU Systems has achieved a significant scientific and commercial breakthrough after successfully producing an electron beam using the world’s first commercial laser-powered particle accelerator. The development marks a major step towards making advanced accelerator technology more compact, cost-effective, and widely accessible across industries.
This achievement represents a defining moment in the evolution of accelerator science — traditionally dominated by massive, government-funded research facilities. TAU’s innovation offers the potential to democratise high-end particle acceleration for a wide range of industrial applications, from semiconductors to healthcare and defence.
Compact design delivers cutting-edge performance
The milestone follows months of work refining TAU’s proprietary accelerator design. At its core is TAU’s state-of-the-art 100-Hz laser system, supplied by Thales, which has demonstrated exceptional stability and reliability.
Using this laser, the company has successfully accelerated electrons in a plasma close to the speed of light — a feat never before achieved in a commercial system. Crucially, the process was demonstrated using a compact setup designed for replication in standard industrial settings.
“This represents a fundamental shift in how we think about particle accelerators,” said Bjorn Manuel Hegelich, founder and CEO at TAU Systems. “We’ve taken technology that typically requires massive facilities kilometres long and made it compact and commercially viable, opening new possibilities for industries that need advanced testing and research capabilities.”
Overcoming traditional accelerator limitations
Conventional particle accelerators are vital to modern science and technology, powering research in materials science, medicine, and physics. However, their enormous size and billion-dollar price tags have limited their use to national laboratories and elite academic institutions.
TAU’s laser-powered approach achieves comparable performance to these large-scale systems while drastically reducing both footprint and cost. This shift could open up new opportunities for private sector applications and smaller research organisations.
Applications across high-tech industries
The company’s innovation arrives at a crucial time, as multiple industries face growing demands for advanced testing and imaging capabilities.
-
Semiconductors: As microchips become more complex, 3D imaging and radiation hardness testing — both enabled by TAU’s accelerator — are becoming critical.
-
Space: Satellite and spacecraft components require rigorous radiation effects testing to ensure long-term reliability.
-
Defence: Military-grade electronics must withstand extreme environmental and operational stress.
-
Healthcare: Compact accelerators could unlock new possibilities for medical imaging and therapeutic treatment modalities.
Next steps and future integration
TAU Systems is now pursuing two parallel development tracks. The newly commissioned accelerator will undergo a systematic ramp-up to full operational capability in the coming months. At the same time, the company continues developing semiconductor metrology and radiation testing techniques for space-bound electronics at its University of Texas at Austin laboratory.
By 2026, TAU expects to integrate these technologies into a full commercial offering, providing radiation effects testing services to both government and private sector clients. This capability addresses a key bottleneck in advanced electronics development, particularly for applications that demand reliability in extreme environments such as deep space and high-performance computing.
A paradigm shift in accelerator accessibility
Founded with a mission to make high-energy physics tools commercially viable, TAU Systems’ latest success cements its status as a pioneer in laser-driven particle acceleration. If the company’s technology continues to prove scalable and reliable, it could fundamentally transform access to high-energy physics — moving accelerators out of exclusive research institutions and into industrial, defence, and healthcare applications.
